Skip navigation

Pharmaceutical Regulation and Product Liability

21st April 2006


  • Recent Developments in US Pharmaceutical Regulation: Update on FDA Physician Labelling Rule
  • The importance of dialogue between regulators
  • 'The changing shape of Pharmaceutical risk'
  • The PREP Act: Liability Protection to Ensure Public Health Protection Against Pandemic Flu
  • Regulation under the scrutiny of the Media
  • The financial impact of pharmaceutical regulation and litigation
  • Obstacles to access to justice in pharmaceutical cases
  • A worldwide Forum?
  • European trends in pharmaceutical litigation
  • US trends in pharmaceutical litigation
  • Liability arising from clinical trials
  • Global regulation of pharmaceuticals: dialogue, efficiency, safety
  • Challenges of a world-wide pharmaceutical law suit

7 CPD hours may be claimed by both solicitors and barristers through attendance at this event.

This event has been kindly sponsored by

4 New Square Logo Lovells

Institute members may access papers from this event by following this link.

23rd November 2017 | LONDON

The standard of review of national court decisions by investment tribunals

Read more

27th November 2017 | LONDON

40th FA Mann Lecture

Read more

4th December 2017 | LONDON

Harry Weinrebe Annual Lecture: Perspectives on 15 years in Business and Human Rights - and on where we may be going next

Read more

6th December 2017 | LONDON

16th Annual Review of the Arbitration Act

Read more

11th December 2017 | LONDON

Legal consequences of the separation of the Chagos Archipelago from Mauritius (ICJ Advisory Opinion)

Read more